Abstract
The identification of reliable biomarkers of immune checkpoint inhibitors (ICI) efficacy is a high priority. Host-related parameters including gut microbiota (Routy B Science 2018, Derosa L Nature Med 2022) and resting energy expenditure (Boudou-Rouquette P Ebiomedecine 2021) have recently emerged. We hypothesized that 18F-FDG colonic uptake might be a surrogate marker for gut microbiome composition, influence energy expenditure and help to identify responders to ICI.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
